We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Bone marrow aspirate of a pediatric patient with acute lymphoblastic leukemia (Photo courtesy of St. Jude Children’s Research Hospital)

Pediatric Acute Lymphoblastic Leukemia Monitored by DNA Sequencing

Blood plasma sequencing appears to offer a noninvasive method for tracking disease clearance or persistence in children with acute lymphoblastic leukemia (ALL), along with the presence or absence of potentially infectious microbes. More...
26 Apr 2022
Image: The FAST System runs the FAST-PBC Prep Cartridges (Photo courtesy of Qvella)

Positive Blood Culture Processing Technology Accelerates Infection Identification and AST

Sepsis is the most deadly and costly hospital condition to treat. Now, a new system has the potential to expedite ID and AST for blood-borne pathogens from positive blood cultures. More...
26 Apr 2022
Image: Urine test for bladder cancer could replace 1000s of invasive cystoscopies each year (Photo courtesy of Pexels)

Urine Test for Bladder Cancer Could Reduce Need for Invasive Cystoscopies

Researchers at the University of Birmingham (Birmingham, UK) have developed a new urine test for bladder cancer that could reduce the need for invasive and time-consuming diagnostic procedures. More...
26 Apr 2022
Image: Rapid virus test delivers results as accurate as lab tests within 30 minutes (Photo courtesy of University of Texas at Dallas)

Rapid Virus Test Delivers Lab Quality Results within 30 Minutes

Researchers have developed a rapid test for viruses that can deliver results as accurate as lab tests within 30 minutes. The technology can be applied to viruses that cause respiratory syncytial virus, influenza and COVID-19. More...
26 Apr 2022
Image: Actiphage is a promising new diagnostic test for tuberculosis infection (Photo courtesy of Pexels)

Blood Test Identifies Those at High Risk of Developing Human Tuberculosis

New research presented at ECCMID 2022 has shown that Actiphage, a new blood test for Mycobacterium tuberculosis (Mtb) can improve identification of those at risk of progressive tuberculosis infection, offering potential for a rapid, non-invasive biomarker for early screening of asymptomatic individuals. More...
26 Apr 2022
Image: Blood-based assay could aid management of relapsing-remitting form of MS (Photo courtesy of Quanterix)

NfL Blood Test to Aid Prognosis and Treatment of Multiple Sclerosis

A blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease. More...
25 Apr 2022
Image: The CRC-PREVENT study will evaluate individuals at risk for colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Based Noninvasive Gut Tests Enable Early Colorectal Cancer Screening

A new diagnostic platform uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. Unlike other noninvasive screening options that use DNA or blood-based biomarkers, the proprietary method from Geneoscopy Inc. (St. Louis, MO, USA) analyzes RNA extracted from patient stool samples to provide the phenotypic and quantitative information necessary to accurately detect precancerous lesions. More...
25 Apr 2022
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Blood Glucose Test Strip
AutoSense Test


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
GLOBE SCIENTIFIC, LLC